Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review

Anti-amyloid monoclonal antibody therapies in Alzheimer’s disease – a scoping review

<p dir="ltr">Alzheimer’s disease (AD) is a progressive neurodegenerative disorder affecting millions worldwide, and with advancements in the medical field, Anti-amyloid monoclonal antibodies (AA mAbs) targeting amyloid-β have emerged as potential disease-modifying agents altering AD...

Full description

Saved in:
Bibliographic Details
Main Author: Shahd Abubaker Elamin (22569539) (author)
Other Authors: Aous N. Al Shibli (22569540) (author), Abdullah Shaito (20545181) (author), Mazyona J.M.B. Al-Maadhadi (22569543) (author), Monica Zolezzi (10115698) (author), Shona Pedersen (2792278) (author)
Published: 2025
Subjects:
Biological sciences
Biochemistry and cell biology
Biomedical and clinical sciences
Neurosciences
Pharmacology and pharmaceutical sciences
Health sciences
Epidemiology
Public health
Alzheimer’s disease
Anti-amyloid monoclonal antibodies
Efficacy
Safety
Clinical trials
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items